Classical models of pattern formation are based on diffusion-driven instability (DDI) of constant stationary solutions of reaction-diffusion equations, which leads to emergence of stable, regular Turing patterns formed around that equilibrium. In this paper we show that coupling reaction-diffusion equations with ordinary differential equations (ODE) may lead to a novel pattern formation phenomenon in which DDI causes destabilization of both constant solutions and Turing patterns. Bistability and hysteresis effects in the null sets of model nonlinearities yield formation of far from the equilibrium patterns with jump discontinuity. We derive conditions for stability of stationary solutions with jump discontinuity in a suitable topology which allows us to include the discontinuity points and leads to the definition of (ε 0 , A)-stability. Additionally, we provide conditions on stability of patterns in a quasi-stationary model reduction. The analysis is illustrated on the example of three-component model of receptor-ligand binding. The proposed model provides an example of a mechanism of de novo formation of far from the equilibrium patterns in reaction-diffusion-ODE models involving co-existence of DDI and hysteresis.
Coupling a reaction-diffusion equation with ordinary differential equations (ODE) may lead to diffusion-driven instability (DDI) which, in contrast to the classical reaction-diffusion models, causes destabilization of both, constant solutions and Turing patterns. Using a shadow-type limit of a reaction-diffusion-ODE model, we show that in such cases the instability driven by nonlocal terms (a counterpart of DDI) may lead to formation of unbounded spike patterns.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.